Publikationen von Tjalf Ziemssen
Alle Typen
Zeitschriftenartikel (6)
2005
Zeitschriftenartikel
175 (1), S. 69 - 81 (2005)
Autoimmune CD4(+) T cell memory: Lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires. Journal of Immunology
Zeitschriftenartikel
233 (1-2), S. 109 - 112 (2005)
Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy. Journal of the Neurological Sciences 2004
Zeitschriftenartikel
199 (2), S. 185 - 197 (2004)
The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. Journal of Experimental Medicine 2002
Zeitschriftenartikel
125, S. 2381 - 2391 (2002)
Glatiramer acetate-specific T-helper 1-and 2-type cell lines produce BDNF: Implications for multiple sclerosis therapy. Brain
Zeitschriftenartikel
73 (4), S. 321 - 331 (2002)
Treatment of multiple sclerosis with glatiramer acetate - new information about its mechanisms of action, pharmacokinetics, adverse effects and clinical studies. Nervenarzt
Zeitschriftenartikel
24 (13), S. 979 - 990 (2002)
Risk-benefit assessment of glatiramer acetate in multiple sclerosis. Drug Safety Buchkapitel (1)
2004
Buchkapitel
Neuroprotection and glatiramer acetate: The possible role in the treatment of Multiple Sclerosis. In: FRONTIERS IN CLINICAL NEUROSCIENCE: NEURODEGENERATION AND NEUROPROTECTION, S. 111 - 134 (Hg. Vecsei, L.). KLUWER ACADEMIC/PLENUM PUBL, NEW YORK (2004)